ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Venous Thromboembolism Prophylaxis Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-32G15060
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Venous Thromboembolism Prophylaxis Market Insights Forecast to 2029
BUY CHAPTERS

Global Venous Thromboembolism Prophylaxis Market Research Report 2025

Code: QYRE-Auto-32G15060
Report
March 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Arjo
Encompass Group
Talley Group
Mego Afek
Zenith Technical Innovations
NormaTec
Bio Compression Systems
ThermoTek USA

Venous Thromboembolism Prophylaxis Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Venous Thromboembolism Prophylaxis Market

Venous Thromboembolism Prophylaxis Market

The global market for Venous Thromboembolism Prophylaxis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Venous Thromboembolism (VTE) prophylaxis refers to the medical measures and interventions aimed at preventing the formation of blood clots within the veins, specifically deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE occurs when a blood clot forms in a deep vein, typically in the legs, and can potentially dislodge and travel to the lungs, causing a life-threatening pulmonary embolism.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Prophylaxis.
The Venous Thromboembolism Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Venous Thromboembolism Prophylaxis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Venous Thromboembolism Prophylaxis Market Report

Report Metric Details
Report Name Venous Thromboembolism Prophylaxis Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Arjo, Encompass Group, Talley Group, MEGO AFEK, Zenith Technical Innovations, Normatec, Bio Compression Systems, ThermoTek USA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Venous Thromboembolism Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Venous Thromboembolism Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Venous Thromboembolism Prophylaxis Market report?

Ans: The main players in the Venous Thromboembolism Prophylaxis Market are Arjo, Encompass Group, Talley Group, MEGO AFEK, Zenith Technical Innovations, Normatec, Bio Compression Systems, ThermoTek USA

What are the Application segmentation covered in the Venous Thromboembolism Prophylaxis Market report?

Ans: The Applications covered in the Venous Thromboembolism Prophylaxis Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Venous Thromboembolism Prophylaxis Market report?

Ans: The Types covered in the Venous Thromboembolism Prophylaxis Market report are Lower Extremity, Upper Extremity

Recommended Reports

Thrombosis Devices

Hemostasis & Anticoagulants

VTE Management Solutions

1 Venous Thromboembolism Prophylaxis Market Overview
1.1 Product Definition
1.2 Venous Thromboembolism Prophylaxis by Type
1.2.1 Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lower Extremity
1.2.3 Upper Extremity
1.3 Venous Thromboembolism Prophylaxis by Application
1.3.1 Global Venous Thromboembolism Prophylaxis Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Venous Thromboembolism Prophylaxis Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Prophylaxis Revenue 2020-2031
1.4.2 Global Venous Thromboembolism Prophylaxis Sales 2020-2031
1.4.3 Global Venous Thromboembolism Prophylaxis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Venous Thromboembolism Prophylaxis Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Venous Thromboembolism Prophylaxis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Type & Application
2.7 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
2.8 Global Venous Thromboembolism Prophylaxis Market Competitive Situation and Trends
2.8.1 Global Venous Thromboembolism Prophylaxis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Venous Thromboembolism Prophylaxis Players Market Share by Revenue
2.8.3 Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Venous Thromboembolism Prophylaxis Market Scenario by Region
3.1 Global Venous Thromboembolism Prophylaxis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Venous Thromboembolism Prophylaxis Sales by Region: 2020-2031
3.2.1 Global Venous Thromboembolism Prophylaxis Sales by Region: 2020-2025
3.2.2 Global Venous Thromboembolism Prophylaxis Sales by Region: 2026-2031
3.3 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2020-2031
3.3.1 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2020-2025
3.3.2 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2026-2031
3.4 North America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.4.1 North America Venous Thromboembolism Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Venous Thromboembolism Prophylaxis Sales by Country (2020-2031)
3.4.3 North America Venous Thromboembolism Prophylaxis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.5.1 Europe Venous Thromboembolism Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Venous Thromboembolism Prophylaxis Sales by Country (2020-2031)
3.5.3 Europe Venous Thromboembolism Prophylaxis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venous Thromboembolism Prophylaxis Market Facts & Figures by Region
3.6.1 Asia Pacific Venous Thromboembolism Prophylaxis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Venous Thromboembolism Prophylaxis Sales by Region (2020-2031)
3.6.3 Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.7.1 Latin America Venous Thromboembolism Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Venous Thromboembolism Prophylaxis Sales by Country (2020-2031)
3.7.3 Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.8.1 Middle East and Africa Venous Thromboembolism Prophylaxis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Venous Thromboembolism Prophylaxis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2020-2031)
4.1.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2020-2025)
4.1.2 Global Venous Thromboembolism Prophylaxis Sales by Type (2026-2031)
4.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2020-2031)
4.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2020-2031)
4.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Type (2020-2025)
4.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2026-2031)
4.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2020-2031)
4.3 Global Venous Thromboembolism Prophylaxis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2020-2031)
5.1.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2020-2025)
5.1.2 Global Venous Thromboembolism Prophylaxis Sales by Application (2026-2031)
5.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2020-2031)
5.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2020-2031)
5.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Application (2020-2025)
5.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2026-2031)
5.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2020-2031)
5.3 Global Venous Thromboembolism Prophylaxis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Arjo
6.1.1 Arjo Company Information
6.1.2 Arjo Description and Business Overview
6.1.3 Arjo Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Arjo Venous Thromboembolism Prophylaxis Product Portfolio
6.1.5 Arjo Recent Developments/Updates
6.2 Encompass Group
6.2.1 Encompass Group Company Information
6.2.2 Encompass Group Description and Business Overview
6.2.3 Encompass Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Encompass Group Venous Thromboembolism Prophylaxis Product Portfolio
6.2.5 Encompass Group Recent Developments/Updates
6.3 Talley Group
6.3.1 Talley Group Company Information
6.3.2 Talley Group Description and Business Overview
6.3.3 Talley Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Talley Group Venous Thromboembolism Prophylaxis Product Portfolio
6.3.5 Talley Group Recent Developments/Updates
6.4 MEGO AFEK
6.4.1 MEGO AFEK Company Information
6.4.2 MEGO AFEK Description and Business Overview
6.4.3 MEGO AFEK Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MEGO AFEK Venous Thromboembolism Prophylaxis Product Portfolio
6.4.5 MEGO AFEK Recent Developments/Updates
6.5 Zenith Technical Innovations
6.5.1 Zenith Technical Innovations Company Information
6.5.2 Zenith Technical Innovations Description and Business Overview
6.5.3 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Portfolio
6.5.5 Zenith Technical Innovations Recent Developments/Updates
6.6 Normatec
6.6.1 Normatec Company Information
6.6.2 Normatec Description and Business Overview
6.6.3 Normatec Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Normatec Venous Thromboembolism Prophylaxis Product Portfolio
6.6.5 Normatec Recent Developments/Updates
6.7 Bio Compression Systems
6.7.1 Bio Compression Systems Company Information
6.7.2 Bio Compression Systems Description and Business Overview
6.7.3 Bio Compression Systems Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio Compression Systems Venous Thromboembolism Prophylaxis Product Portfolio
6.7.5 Bio Compression Systems Recent Developments/Updates
6.8 ThermoTek USA
6.8.1 ThermoTek USA Company Information
6.8.2 ThermoTek USA Description and Business Overview
6.8.3 ThermoTek USA Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ThermoTek USA Venous Thromboembolism Prophylaxis Product Portfolio
6.8.5 ThermoTek USA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venous Thromboembolism Prophylaxis Industry Chain Analysis
7.2 Venous Thromboembolism Prophylaxis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venous Thromboembolism Prophylaxis Production Mode & Process Analysis
7.4 Venous Thromboembolism Prophylaxis Sales and Marketing
7.4.1 Venous Thromboembolism Prophylaxis Sales Channels
7.4.2 Venous Thromboembolism Prophylaxis Distributors
7.5 Venous Thromboembolism Prophylaxis Customer Analysis
8 Venous Thromboembolism Prophylaxis Market Dynamics
8.1 Venous Thromboembolism Prophylaxis Industry Trends
8.2 Venous Thromboembolism Prophylaxis Market Drivers
8.3 Venous Thromboembolism Prophylaxis Market Challenges
8.4 Venous Thromboembolism Prophylaxis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Arjo
Encompass Group
Talley Group
Mego Afek
Zenith Technical Innovations
NormaTec
Bio Compression Systems
ThermoTek USA
List of Tables
 Table 1. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Venous Thromboembolism Prophylaxis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Venous Thromboembolism Prophylaxis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Venous Thromboembolism Prophylaxis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Venous Thromboembolism Prophylaxis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Type & Application
 Table 12. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Venous Thromboembolism Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Prophylaxis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Venous Thromboembolism Prophylaxis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Venous Thromboembolism Prophylaxis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2020-2025)
 Table 19. Global Venous Thromboembolism Prophylaxis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2026-2031)
 Table 21. Global Venous Thromboembolism Prophylaxis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2020-2025)
 Table 23. Global Venous Thromboembolism Prophylaxis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2026-2031)
 Table 25. North America Venous Thromboembolism Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Venous Thromboembolism Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Venous Thromboembolism Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Venous Thromboembolism Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Venous Thromboembolism Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Venous Thromboembolism Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Venous Thromboembolism Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Venous Thromboembolism Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Venous Thromboembolism Prophylaxis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Venous Thromboembolism Prophylaxis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Venous Thromboembolism Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Venous Thromboembolism Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Venous Thromboembolism Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Venous Thromboembolism Prophylaxis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Venous Thromboembolism Prophylaxis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Type (2020-2025)
 Table 51. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Type (2026-2031)
 Table 52. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2020-2025)
 Table 53. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2026-2031)
 Table 54. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2020-2025)
 Table 57. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2026-2031)
 Table 58. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Application (2020-2025)
 Table 61. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Application (2026-2031)
 Table 62. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2020-2025)
 Table 63. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2026-2031)
 Table 64. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2020-2025)
 Table 67. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2026-2031)
 Table 68. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2026-2031)
 Table 70. Arjo Company Information
 Table 71. Arjo Description and Business Overview
 Table 72. Arjo Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Arjo Venous Thromboembolism Prophylaxis Product
 Table 74. Arjo Recent Developments/Updates
 Table 75. Encompass Group Company Information
 Table 76. Encompass Group Description and Business Overview
 Table 77. Encompass Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Encompass Group Venous Thromboembolism Prophylaxis Product
 Table 79. Encompass Group Recent Developments/Updates
 Table 80. Talley Group Company Information
 Table 81. Talley Group Description and Business Overview
 Table 82. Talley Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Talley Group Venous Thromboembolism Prophylaxis Product
 Table 84. Talley Group Recent Developments/Updates
 Table 85. MEGO AFEK Company Information
 Table 86. MEGO AFEK Description and Business Overview
 Table 87. MEGO AFEK Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MEGO AFEK Venous Thromboembolism Prophylaxis Product
 Table 89. MEGO AFEK Recent Developments/Updates
 Table 90. Zenith Technical Innovations Company Information
 Table 91. Zenith Technical Innovations Description and Business Overview
 Table 92. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product
 Table 94. Zenith Technical Innovations Recent Developments/Updates
 Table 95. Normatec Company Information
 Table 96. Normatec Description and Business Overview
 Table 97. Normatec Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Normatec Venous Thromboembolism Prophylaxis Product
 Table 99. Normatec Recent Developments/Updates
 Table 100. Bio Compression Systems Company Information
 Table 101. Bio Compression Systems Description and Business Overview
 Table 102. Bio Compression Systems Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bio Compression Systems Venous Thromboembolism Prophylaxis Product
 Table 104. Bio Compression Systems Recent Developments/Updates
 Table 105. ThermoTek USA Company Information
 Table 106. ThermoTek USA Description and Business Overview
 Table 107. ThermoTek USA Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. ThermoTek USA Venous Thromboembolism Prophylaxis Product
 Table 109. ThermoTek USA Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Venous Thromboembolism Prophylaxis Distributors List
 Table 113. Venous Thromboembolism Prophylaxis Customers List
 Table 114. Venous Thromboembolism Prophylaxis Market Trends
 Table 115. Venous Thromboembolism Prophylaxis Market Drivers
 Table 116. Venous Thromboembolism Prophylaxis Market Challenges
 Table 117. Venous Thromboembolism Prophylaxis Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Venous Thromboembolism Prophylaxis
 Figure 2. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Venous Thromboembolism Prophylaxis Market Share by Type: 2024 & 2031
 Figure 4. Lower Extremity Product Picture
 Figure 5. Upper Extremity Product Picture
 Figure 6. Global Venous Thromboembolism Prophylaxis Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Venous Thromboembolism Prophylaxis Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Venous Thromboembolism Prophylaxis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Venous Thromboembolism Prophylaxis Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Venous Thromboembolism Prophylaxis Sales (2020-2031) & (K Units)
 Figure 14. Global Venous Thromboembolism Prophylaxis Average Price (US$/Unit) & (2020-2031)
 Figure 15. Venous Thromboembolism Prophylaxis Report Years Considered
 Figure 16. Venous Thromboembolism Prophylaxis Sales Share by Manufacturers in 2024
 Figure 17. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Venous Thromboembolism Prophylaxis Players: Market Share by Revenue in Venous Thromboembolism Prophylaxis in 2024
 Figure 19. Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Venous Thromboembolism Prophylaxis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Venous Thromboembolism Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 22. North America Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 23. United States Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 26. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Venous Thromboembolism Prophylaxis Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2020-2031)
 Figure 34. China Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Venous Thromboembolism Prophylaxis Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Venous Thromboembolism Prophylaxis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Venous Thromboembolism Prophylaxis by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Venous Thromboembolism Prophylaxis by Type (2020-2031)
 Figure 55. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Venous Thromboembolism Prophylaxis by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Venous Thromboembolism Prophylaxis by Application (2020-2031)
 Figure 58. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2020-2031)
 Figure 59. Venous Thromboembolism Prophylaxis Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Venous Thromboembolism VTE Devices Market Insights Forecast to 2030
Global Venous Thromboembolism Therapy Market Research Report 2025
Global Venous Thromboembolism VTE Intelligent Prevention and Treatment System Market Research Report 2024
Global Venous Thromboembolism VTE Prevention Software Market Research Report 2024
Global VTE Mechanical Prevention Market Research Report 2025
Global VTE Prevention Static System Market Research Report 2025
Global VTE Prevention Dynamical System Market Research Report 2025
VTE Preventive Clothing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VTE Prevention Garments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VTE Prevention Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venous Thromboembolism Therapeutics Market Research Report 2025
Deep Vein Thrombosis DVT Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vena Cava Filter System Market Research Report 2024
Global Deep Vein Thrombosis DVT Pumps Market Insights Forecast to 2030
Venous Thromboembolism Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombosis Drug Market Research Report 2025
Global Medical Vena Cava Filter System Market Research Report 2024
Deep Vein Thrombosis DVT Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DVT Preventive Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venous Thromboembolism Treatment Options Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions